Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06652815 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Cognition, Metacognition, and Stigma in Patients With Suicidal Ideation

StatusNot Yet Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 6 months later Dec 31, 2027 → Jun 30, 2028
See other at-risk trials from University of Pittsburgh

Record History

  1. Primary completion pushed from Dec 31, 2027 to Jun 30, 2028 Start date: Dec 1, 2026 to Jun 1, 2027 · Completion pushed from Mar 31, 2028 to Dec 31, 2028 · Enrollment target: 220 to 212 · 2 more Show 5 more changesShow less
    • Start date: Dec 1, 2026 to Jun 1, 2027
    • Completion pushed from Mar 31, 2028 to Dec 31, 2028
    • Enrollment target: 220 to 212
    • Eligibility criteria expanded, about 9 words
    • Study description expanded, about 9 words
  2. Primary completion date: Oct 31, 2026 to Dec 31, 2027 Start date: Mar 1, 2026 to Dec 1, 2026 · Completion date: Mar 31, 2027 to Mar 31, 2028v7 Show 2 more changesShow less
    • Start date: Mar 1, 2026 to Dec 1, 2026
    • Completion date: Mar 31, 2027 to Mar 31, 2028
  3. Primary completion date: Apr 30, 2026 to Oct 31, 2026 Start date: Dec 1, 2025 to Mar 1, 2026 · Enrollment target: 212 to 220 · Completion date: Dec 30, 2026 to Mar 31, 2027v6 Show 3 more changesShow less
    • Start date: Dec 1, 2025 to Mar 1, 2026
    • Enrollment target: 212 to 220
    • Completion date: Dec 30, 2026 to Mar 31, 2027
  4. Start date: Aug 1, 2025 to Dec 1, 2025 Primary completion date: Jun 30, 2026 to Apr 30, 2026 · Completion date: Sep 30, 2026 to Dec 30, 2026v5 Show 2 more changesShow less
    • Primary completion date: Jun 30, 2026 to Apr 30, 2026
    • Completion date: Sep 30, 2026 to Dec 30, 2026
  5. Primary completion date: Dec 31, 2025 to Jun 30, 2026 Start date: Apr 1, 2025 to Aug 1, 2025 · Completion date: Mar 31, 2026 to Sep 30, 2026v4 Show 2 more changesShow less
    • Start date: Apr 1, 2025 to Aug 1, 2025
    • Completion date: Mar 31, 2026 to Sep 30, 2026
Show 2 earlier versionsHide 2 earlier versions
  1. Start date: Feb 1, 2025 to Apr 1, 2025 Primary completion date: Oct 31, 2025 to Dec 31, 2025v3 Show 1 more changeShow less
    • Primary completion date: Oct 31, 2025 to Dec 31, 2025
  2. Start date: Dec 1, 2024 to Feb 1, 2025 Primary completion date: Aug 31, 2025 to Oct 31, 2025 · Completion date: Dec 31, 2025 to Mar 31, 2026v2 Show 2 more changesShow less
    • Primary completion date: Aug 31, 2025 to Oct 31, 2025
    • Completion date: Dec 31, 2025 to Mar 31, 2026
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Deficits of executive function, meta cognition and stigma is known in suicidal ideation; however, their relationship is unknown. Since many studies use a single indicator of executive function and, it was considered important to study. Metacognition, executive functioning and stigma are the possible driving force behind the suicidal behavior in human being. With respect to research in the Indian context, there is paucity of studies exploring these factors. The purpose of the present study is to explore the relationships between executive functioning, metacognition, and stigma in suicidal ideation and suicide attempters in the Indian setup, where there is a lacuna in research regarding the same. Having a detailed understanding of these psychological parameters will be helpful in suicide prevention and management.
Trial Details
NCT Number NCT06652815
Lead Sponsor University of Pittsburgh
Collaborators: Fogarty International Center of the National Institute of Health
Conditions Persons With High Suicide Ideation or Attempts
Enrollment 212 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov